Course Description: This presentation discusses HCV stigmatization, barriers to HCV care, provider and patient education efforts with respect to HCV, different prevention approaches for HCV, how HCV works biologically and scientifically, geographic, chronological, and demographic trends in HCV transmission, risk factors for HCV transmission, the effects of HCV on the body, HCV treatment options, HCV testing, HCV legal and medical guidelines, and recent and upcoming advances in HCV treatment and prevention.
Faculty:
Learning Objectives:
Faculty:
- Allyson L. Ishihara, MSW, LCSWA - Licensed Clinical Social Worker at Wake County Health & Human Services - Division of Public Health
- Professor Mark Sulkowski, M.D., Johns Hopkins University School of Medicine, Baltimore, USA
Learning Objectives:
- Analyze Hepatitis C demographics to identify hidden patterns and target high-risk populations effectively.
- Describe the revolutionary impact of direct-acting antivirals (DAAs) on Hepatitis C treatment outcomes.
- Explain the significance of universal HCV testing in reducing transmission rates and enhancing public health outcomes.
- Discuss the rationale behind universal HCV treatment and its role in reducing disease burden.
- Navigate simplified HCV treatment guidelines and apply them to patient-centered approaches.
- Evaluate strategies for treating and preventing HCV transmission, focusing on high-risk populations and overcoming barriers to care
NOTE: This session does not offer continuing education credits.